[JAK2 (V617F) is a risk factor for thrombosis in essential thrombocythemia/link may exist between leukocytosis, JAK2 (V617F), & the hemostatic system activation in patients with Bcl-negative myeloproliferative disorders/. ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE